What is the ideal Adrenocorticotropic hormone (ACTH) level for a patient being treated for Addison's disease?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 7, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

ACTH Levels in Treated Addison's Disease

In patients with Addison's disease, ACTH levels should be elevated between 75-700 pg/ml, which indicates appropriate glucocorticoid replacement therapy. 1

Understanding ACTH in Addison's Disease

  • Primary adrenal insufficiency (Addison's disease) is characterized by inadequate production of cortisol and aldosterone from the adrenal cortex 2
  • Diagnosis typically shows low serum cortisol with elevated ACTH levels 2
  • When treating Addison's disease, the goal is not to normalize ACTH levels but to provide adequate glucocorticoid replacement 3

Interpreting ACTH Levels in Treated Patients

  • ACTH levels below 75 pg/ml suggest over-treatment with glucocorticoids 1
  • ACTH levels between 75-700 pg/ml indicate appropriate glucocorticoid replacement 1
  • ACTH levels above 700 pg/ml suggest under-treatment, often accompanied by high plasma renin activity 1

Glucocorticoid Replacement Guidelines

  • Standard glucocorticoid replacement consists of hydrocortisone 15-25 mg/day or cortisone acetate 20-30 mg/day in 2-3 divided doses 4
  • The largest dose should be given in the morning to mimic natural circadian rhythm 4
  • Monitoring of replacement therapy should be primarily clinical rather than laboratory-based 3
  • Clinical signs of under-replacement include lethargy, nausea, poor appetite, weight loss, and increased pigmentation 3
  • Clinical signs of over-replacement include weight gain, insomnia, and peripheral edema 3

Why ACTH Levels May Remain Elevated Despite Treatment

  • Conventional hydrocortisone replacement may not fully suppress morning ACTH levels 5
  • ACTH levels typically follow a circadian rhythm with peaks in the early morning 6
  • Plasma ACTH levels may be completely suppressed after hydrocortisone doses but rebound to high levels by the following morning 6

Special Considerations

  • Some patients with persistently high ACTH levels may benefit from alternative regimens, such as combining hydrocortisone with dexamethasone in selected cases 6, 5
  • Pituitary hyperplasia can develop in Addison's disease patients and contribute to elevated ACTH levels 5
  • The renin-angiotensin system may play a role in maintaining high ACTH levels in some patients 1

Practical Management Approach

  • Focus on clinical assessment rather than targeting specific ACTH levels 3, 4
  • Evaluate energy levels, mental concentration, pigmentation changes, and weight for signs of under or over-replacement 3
  • If ACTH levels are persistently very high (>700 pg/ml) despite clinical well-being, consider evaluating mineralocorticoid replacement adequacy 1
  • For patients with morning ACTH surges, consider adjusting the timing of hydrocortisone doses or alternative regimens 6

Common Pitfalls to Avoid

  • Don't target normal ACTH levels as the primary goal of treatment 3, 4
  • Don't increase glucocorticoid doses based solely on elevated ACTH levels without clinical symptoms of under-replacement 3
  • Don't overlook the importance of mineralocorticoid replacement (fludrocortisone) which may indirectly affect ACTH levels 1
  • Don't use synthetic glucocorticoids like dexamethasone as first-line treatment due to potential undesirable metabolic long-term effects 7

References

Guideline

Addison's Disease Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Treatment of Adrenal Disorders

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Replacement therapy for Addison's disease: recent developments.

Expert opinion on investigational drugs, 2008

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.